BioSpace News Archive

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for rare diseases, announced that a broad set of clinical and translational data from its programs will be presented at the 65th American Society of Hematology Annual Meeting & Exposition, to be held Dec. 9-12, 2023, in San Diego.

Scilex Holding Company, an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, announced a peer-review publication which contains results of skin penetration studies conducted at the Institute for Biomedical Research and Technologies, Graz, Austria.

Biomea Fusion, Inc. announced that abstracts related to BMF-219 and BMF-500 have been accepted for presentation at the upcoming American Society of Hematology Annual Meeting, to be held in San Diego from December 9-12, 2023.

Abbott has received U.S. Food and Drug Administration approval for its molecular human papillomavirus or HPV screening solution, adding a powerful cancer screening tool for detecting high-risk HPV infections to the Alinity m family of diagnostic assays.

Chroma Medicine, Inc. announced that it will present a poster demonstrating the potential of its multiplex epigenetic editing platform at the American Society of Hematology 65th Annual Meeting, taking place December 9-12, 2023, in San Diego, CA.

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced the creation of the HiFi Solves consortium.

Actinium Pharmaceuticals, Inc. announced that three abstracts detailing results from the completed Phase 3 SIERRA trial of Iomab-B in patients age 55 and above with active relapsed or refractory acute myeloid leukemia have been accepted for presentation at the 65th Annual American Society of Hematology Annual Meeting & Exposition being held in San Diego on December 9-12, 2023.

The Hans Wigzell Research Foundation announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research, is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.

Protagonist Therapeutics, Inc. announced today that five abstracts relevant to the Company’s rusfertide program have been accepted for presentation at the 65th American Society of Hematology Annual Meeting and Exposition (ASH), taking place December 9-12, 2023 in San Diego, California.

Veracyte, Inc . (Nasdaq: VCYT) announced today that Rebecca Chambers, chief financial officer, will participate in a fireside chat at the Stephens Annual Investment Conference on Wednesday, November 15, at 3:00 p.m. Eastern Time.